The top Democrat on the House Oversight and Government Reform Committee is calling for the White House to brief the panel on its efforts to implement recommendations from the president's opioid commission.

Rep. Elijah Cummings Elijah Eugene CummingsBlack GOP candidate accuses Behar of wearing black face in heated interview Overnight Health Care: US won't join global coronavirus vaccine initiative | Federal panel lays out initial priorities for COVID-19 vaccine distribution | NIH panel: 'Insufficient data' to show treatment touted by Trump works House Oversight Democrats to subpoena AbbVie in drug pricing probe MORE (D-Md.) wrote a letter to Oversight Chairman Trey Gowdy Harold (Trey) Watson GowdySunday shows preview: Election integrity dominates as Nov. 3 nears Tim Scott invokes Breonna Taylor, George Floyd in Trump convention speech Sunday shows preview: Republicans gear up for national convention, USPS debate continues in Washington MORE (R-S.C.) on Friday urging him to request the briefing from presidential counselor Kellyanne Conway Kellyanne Elizabeth ConwayGeorge and Kellyanne Conway honor Ginsburg Trump carries on with rally, unaware of Ginsburg's death George Conway hits Trump on 9/11 anniversary: 'The greatest threat to the safety and security of Americans' MORE, who has helmed the White House's efforts to combat the opioid epidemic.

“I understand that President Trump Donald John TrumpUS reimposes UN sanctions on Iran amid increasing tensions Jeff Flake: Republicans 'should hold the same position' on SCOTUS vacancy as 2016 Trump supporters chant 'Fill that seat' at North Carolina rally MORE has designated Kellyanne Conway as his point person on this issue, so her input would help the Committee with its ongoing efforts to evaluate the status of the Commission’s recommendations,” Cummings wrote.

ADVERTISEMENT

Cummings expressed frustration at a prior effort to request a briefing from the White House, alleging that Gowdy’s staff declined to help make the request. Cummings also claimed that Gowdy requested a briefing from the Office of National Drug Control Policy (ONDCP) but that the letter was sent without asking Cummings to join.

Though committee staff from both parties met with ONDCP earlier this week, Cummings wrote that it was vital to also secure a briefing with the administration to hear about its efforts to implement the opioid commission's nearly 60 recommendations on how to combat the epidemic plaguing the U.S. Those recommendations were issued on Nov. 1.

“One problem with speaking only with ONDCP is that President Trump and his top advisors have been trying to decimate ONDCP since the first days of his Administration,” Cummings noted.

A spokesperson for Gowdy did not immediately return a request for comment.

The Office of Management and Budget was weighing proposing to nearly eliminate ONDCP in the president’s budget last year. The plan wasn’t ultimately included, as it received backlash from lawmakers and advocates.

This year, the president’s budget released Monday proposes major changes to ONDCP — moving two of its main grant programs out of the office and into other departments.

Additional news reports have suggested a lack of senior leadership at ONDCP, Cummings wrote. The White House appointed an acting director last week.